Overall rank by patents
#10,317
of 50,000 tracked assignees
USPTO PatentsView assignee record - 30 granted patents across 30 technology areas, recorded in grant years 2015–2016. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
The verdict
According to USPTO PatentsView, Eveready ranks #10,317 of 50,000 tracked US assignees by granted-patent volume, with 30 patents across 30 technology areas.
Eveready Battery Company, Inc. has been granted 30 US utility patents between 2015 and 2016, placing Eveready Battery Company, Inc. at #10,317 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 30 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.8 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a US Corporation, Eveready Battery Company, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Eveready sits between Epicentrx, Inc. (30 patents, rank #10,314) and Feng Chia University (30 patents, rank #10,322) - the closest US assignees by grant volume. The composite Innovation Score of 39.5/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 0 grants, compared with 30 in the 2015–2019 window, a -100% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Eveready Battery Company, Inc.'s 13.8 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 30 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
EPICENTRX, INC.
30 patents
EVERSEEN LIMITED
30 patents
Edge-Works Manufacturing Company
30 patents
Encite LLC
30 patents
Evonik Industries AG
30 patents
ExxonMobil Engineering & Technology Company
30 patents
FACC AG
30 patents
Feng Chia University
30 patents
Eveready Battery Company, Inc.
30 patents
What this shows Eveready holds 30 patents at rank #10,318, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #10,318 in granted patent volume.
Other assignees with the most granted patents in Eveready's primary technology class.
Two PlainPatent-derived peer sets for Eveready, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (40 here).
Eveready's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
40 Top 38% higher than 62% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 28 | 93.3% |
| 2016 | 2 | 6.7% |
Top 15 of 30 technology areas
Historical grant data only; it does not rate legal strength or current strategy.
Overall rank by patents
#10,317
of 50,000 tracked assignees
39.5 out of 100
How to use this portfolio
Eveready's 30 grants land it in the top 38% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.